Amen Clinics puts a picture at the center of psychiatry

A psychiatric appointment usually begins with a story. At Amen Clinics, that story comes with a picture. The company makes images of blood flow in the brain a central part of its evaluation, offering patients something unusually tangible in a field where suffering can be difficult to describe. You can point to a picture. You can bring it home. You can ask someone to explain what it means.

That simple appeal has helped define a national medical brand. Psychiatrist Daniel Amen’s network operates 11 U.S. locations and markets care for children, teenagers, and adults with problems ranging from attention difficulties and depression to memory complaints and head injuries. Its promise is a fuller explanation of what is happening, followed by an individualized plan. Its defining controversy is whether the scan supplies the clinical guidance the company says it does.

The picture is the proposition

SPECT stands for single photon emission computed tomography. It is a nuclear medicine technique that uses a radioactive tracer to map regional blood flow. Amen Clinics interprets these patterns alongside the patient’s history and other assessments. The procedure creates a representation of function, rather than the anatomical portrait people tend to imagine when they hear “brain scan.”

The distinction matters. A striking image is not a diagnosis printed in color. On its own FAQ page, the company states: “A SPECT study by itself will not give a diagnosis.” The physician still has to interpret symptoms, interviews, questionnaires, and testing. Imaging is presented as an additional source of information within that process.

“A SPECT study by itself will not give a diagnosis.”

Amen Clinics · Patient FAQ

The clinic argues that this extra information can reveal overlooked contributors to distress and help clinicians choose treatment. For a family exhausted by competing explanations, that proposition has emotional force. It offers an account of the problem that can be discussed together. Whether the picture improves clinical decisions is a separate question, and the company’s history has been shaped by the distance between those two ideas.

A 1991 lecture, then a lifetime of looking

Amen’s route into psychiatry began with earlier work as an Army medic and X-ray technician. He opened his first clinic in Northern California in 1989. According to the company’s account, attending a lecture on SPECT in 1991 brought his interests in imaging and psychiatry together. That encounter supplied the conviction that became his professional signature.

The company’s origin story describes a change in how its founder understood psychiatric symptoms. He wanted to bring imaging into everyday care, even as other practitioners questioned whether the evidence justified it. There is no need to invent a failed startup or a dramatic financial rescue to make this history interesting. The consequential bet was clinical: put the scan inside the consultation and build the practice around it.

Expansion followed. Orange County joined in 2000, with later openings including Chicago in 2017 and Encino in 2018. Meanwhile, Amen’s books and public television appearances gave people a way to encounter his ideas before they ever considered booking. His first nationally aired public television program arrived in 2008. In this business, the explanation could reach the prospective patient years before the appointment.

The appointment is a bundle

The scan attracts attention, but the service contains considerably more. The clinic’s psychiatric assessment explores four dimensions of a person’s life: biological, psychological, social, and spiritual. That means questions about health and thinking sit beside questions about relationships, purpose, and meaning. The stated ambition is to assemble a fuller history before selecting care.

A comprehensive evaluation typically includes cognitive testing, a physician meeting, imaging, and follow-up, adding up to about 10 hours of clinical care. The company describes two SPECT sessions, one associated with rest and another with concentration. The patient is buying a sequence of encounters and interpretations, rather than simply a file containing a brain image.

The services menu stretches from cognitive behavioral therapy and family therapy to medication management, nutritional services, neurofeedback, and qEEG, which maps electrical activity. Specialized programs address memory, concussion, and sports psychiatry. The breadth makes the network a destination for people seeking several kinds of assessment or support through one organization.

That breadth also complicates the sales pitch. A menu is not a treatment recommendation, and listing services together does not establish that each has equal evidence for every condition. Patients need to understand which component addresses which problem. They also need to distinguish the initial evaluation from the work that follows it. A detailed explanation can begin a course of care; it cannot complete one.

Who pays for the longer conversation?

Amen Clinics operates on a private-pay basis. It does not bill insurance directly. Patients receive documentation that they may submit for possible out-of-network reimbursement, depending on their coverage. That puts the initial financial responsibility on the patient, even when some reimbursement might eventually arrive.

The current pricing process is personalized. A prospective patient contacts the company for an estimate based on recommended services. The clinic offers CareCredit financing, allows HSA/FSA use, and advertises family discounts. Those arrangements affect how someone pays; they do not establish what their complete treatment course will cost.

The useful comparison is an itemized one: evaluation, subsequent appointments, any additional testing, and recommended products or therapies. Travel can matter, too. A person comparing clinics should compare the same scope of care and ask what remains payable after the initial package. A monthly payment figure alone cannot answer that question.

There is a revealing detail in the company’s physician recruitment pitch. It promotes the freedom of working outside insurance constraints alongside opportunities to participate in podcasts, webinars, and books. Clinical work and public communication are both part of the proposition. The network is selling patients more attention while offering clinicians a setting designed to support that model.

A large database is not the last word

Amen Clinics reports roughly 300,000 brain scans, with patients represented from 155 countries. Those are company-reported cumulative figures, and scans should not be confused with individual patients. Its archive is an important part of how the business presents its expertise. A large archive can support research. Size alone does not validate a diagnostic use.

A published study of 109 outpatients examined how adding SPECT information changed clinicians’ assessments in complex cases. That asks a useful question about decision-making. It does not, by itself, demonstrate that the revised decisions produced better outcomes than equally thorough care without imaging. Changing a plan and improving a life are different endpoints.

The independent objection is longstanding. In a 2012 analysis in the AMA Journal of Ethics, Martha Farah and Seth Gillihan described the difficulty of translating differences between groups into reliable diagnoses for individuals. Patterns can overlap across conditions. The attractive simplicity of a picture does not remove that statistical problem.

A 2024 review of routine psychiatric imaging likewise concluded that, beyond limited circumstances, available imaging tests had not demonstrated the benefits needed to diagnose or guide treatment in ordinary psychiatric practice. The dispute concerns particular clinical uses and their evidence. It does not imply that brain imaging has no legitimate medical role.

The company’s September 2026 outcomes presentation gives another view of the practice: patient-reported change after care. Such follow-up is useful, but a package containing several interventions cannot reveal which ingredient produced an improvement. Nor can separate studies with different populations and definitions be treated as a clean contest between clinics. The appropriate question remains what imaging adds.

The founder is famous. The company is employee-owned.

Amen’s name sits on the door, but the company says employees also have an ownership stake. Its recruiting material identifies an Employee Stock Ownership Plan for eligible physicians. The public culture pitch emphasizes shared accountability, collaboration, and continuing brain-health education. These are the organization’s stated commitments, rather than an independent verdict on working there.

Around the clinic network sits a wider collection of founder-led organizations. BrainMD sells supplements; Amen University offers education; the Change Your Brain Foundation supports research, education, and access to care. They extend the reach of the brain-health message. They should not automatically be counted as divisions of the clinic company or combined into a single revenue estimate.

Since 2020, the digital series Scan My Brain has given that message another format: public figures discussing their scans. This makes a technical service easier to picture before purchase. It also makes editorial distinctions essential. A celebrity’s account of feeling better is an individual experience, not a controlled clinical trial.

What travels beyond the scanner

Amen Clinics occupies a recognizable position: outpatient mental health care with a strong imaging identity, extensive assessment, and direct consumer marketing. Its alternatives include independent psychiatrists, psychologists, and hospital-based services. A patient can seek careful assessment and ongoing treatment in those settings without making SPECT the organizing feature.

The company’s process offers a practical lesson that does not depend on accepting every imaging claim. Assemble the history. Explain the plan in understandable language. Make follow-up part of the service. Those are useful standards for evaluating any provider. They become especially valuable when a person has accumulated appointments without a coherent account of what happens next.

The limits follow from the same logic. This model will disappoint someone expecting an image to settle a diagnosis by itself, or assuming the evaluation fee covers every subsequent need. For patients, the decisive conversation is about the proposed treatment, its evidence, its costs, and how progress will be measured. The picture may open that conversation. The care has to carry it.